Lv21
168 积分 2024-05-23 加入
A Randomized Phase II/III Trial of 3 Weekly Intraperitoneal versus Intravenous Carboplatin in Combination with Intravenous Weekly Dose-dense Paclitaxel for Newly Diagnosed Ovarian, Fallopian Tube and Primary Peritoneal Cancer
1小时前
求助中
ICON2: randomised trial of single-agent carboplatin against three-drug combination of CAP (cyclophosphamide, doxorubicin, and cisplatin) in women with ovarian cancer
2小时前
已完结
Systematic Review of First-Line Chemotherapy for Newly Diagnosed Postoperative Patients with Stage II, III, or IV Epithelial Ovarian Cancer
2小时前
已完结
Phase II study of weekly topotecan in patients with recurrent or persistent epithelial ovarian cancer
6天前
已关闭
TLD-1, a Novel Liposomal Doxorubicin, in Patients with Solid Tumors: Comparative Pharmacokinetics and Final Results of a Multicenter Phase 1 Study (SAKK 65/16)
6天前
已完结
[Phase II study of 4'-O-tetrahydropyranyl-adriamycin (THP-ADM) in patients with gynecological cancer]
6天前
已关闭
Upregulation of B3GNT3 is associated with immune infiltration and activation of NF-κB pathway in gynecologic cancers
6个月前
已关闭
活检组织来源的肿瘤类器官对进展期胃癌新辅助化疗预测价值的探究
6个月前
已完结
Differences in chemotherapeutic drug sensitivity before and after patient-derived tumor organoid construction
7个月前
已完结
Organoid models of drug resistant gastric adenosquamous carcinoma: Recapitulating tumor features and refining precision treatment
7个月前
已完结
皖公网安备34019202002308
